A carregar...
Spotlight on the utility of the Oncotype DX(®) breast cancer assay
The Oncotype DX(®) assay was developed to address the need for optimizing the selection of adjuvant systemic therapy for patients with estrogen receptor (ER)-positive, lymph node-negative breast cancer. It has ushered in the era of genomic-based personalized cancer care for ER-positive primary breas...
Na minha lista:
| Publicado no: | Int J Womens Health |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827461/ https://ncbi.nlm.nih.gov/pubmed/29503586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S124520 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|